FDA ‘Encouraged’ By Industry Response To Guidance 213

by | Mar 25, 2014 | News | 0 comments

On December 12, 2013, the Food and Drug administration asked the animal pharmaceutical industry to notify the agency in writing within 90 days of its intent to engage with the FDA as defined in Guidance 213. This request made by the FDA is another part of the plan to help phase out the use of medically important antimicrobials in food animals for food production purposes. As of March 12, 2014, the FDA stated that it has received responses from all the sponsors affected by Guidance 213 and they are in the process of reviewing and analyzing the responses. The response so far has been positive and encouraging to the agency. Read more here about how the industry is responding to Guidance 213.

Recent GVL Blog Posts

Compliant horse travel for 30 days or 6 months?

Compliant horse travel for 30 days or 6 months?

Why acceptance of EECVI continues to grow among veterinarians, horse owners and state animal health officialsA number of state animal health officials launched the Extended Equine Certificate of Veterinary Inspection (EECVI) program in January 2019. EECVIs function...

Q&A and Resources from Safe Air Cargo Transport of Pets Webinar

Q&A and Resources from Safe Air Cargo Transport of Pets Webinar

In our recent webinar, How to Help Clients Prepare for Safe Air Cargo Transport of Pets, Dr. Nelva Bryant presented on what veterinarians can expect with air transport of animals, suggestions to prepare pets for travel via cargo, and the risks and stressors associated...

Support Report from GVL Customer Success

Support Report from GVL Customer Success

To welcome springtime, we’re launching a monthly newsletter created by the Customer Success team to highlight seasonal trends, helpful hints, and GVL news.A view from our desks (at home) As the weather warms across the country, EIA/Coggins season has officially taken...